Psychodynamic Psychopharmacology
- David Mintz, M.D., DFAPA
What if how medication was prescribed was as important as what was prescribed? This is the central tenet of Psychodynamic Psychopharmacology, a new guide that emphasizes integrating research on evidence-based prescribing processes with psychodynamic insights and skills to enhance and optimize treatment outcomes with difficult-to-treat patients.
The book examines the incidence and nature of pharmacological treatment resistance, exploring common psychodynamics that contribute to resistance and preparing readers to better understand and formulate the processes that interfere with the healthy use of medications.
It offers detailed technical recommendations for addressing patient ambivalence, containing countertransference, and avoiding the all-too-common neglect of the psychological and social factors that contribute to treatment resistance.
By putting the patient back at the center of the therapeutic framework, Psychodynamic Psychopharmacology offers a model that moves beyond compliance and emphasizes instead the alliance between patient and prescriber. In doing so, it empowers patients to become more active contributors in their own recovery.
David Mintz, M.D., is Director of Psychiatric Education, Associate Director of Training, and a Team Leader at the Austen Riggs Center in Stockbridge, Massachusetts.
DOI: | https://doi.org/10.1176/appi.books.9781615379064 |
Publisher: | American Psychiatric Publishing |
Copyright Year: | 2022 |
Print Date: | February 10, 2022 |
Online Date: | December 5, 2024 |